BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell…
Oxford Nanopore Technologies today announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete its PromethION product range. Engineered with robust…
Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, announced today that its Simoa® phospho-Tau 217 (p-Tau 217) blood test has been granted Breakthrough Device designation…
Oxford Nanopore sequencing technology has been used to develop a sequencing assay and customised analysis pipeline for the comprehensive and accurate detection of variation at the specific chromosomal location associated…
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced a significant update to the company’s flagship Evercode™ Whole Transcriptome products. Available to ship in…
FFeb 20th 2024, Tuesday, 10-11am NUS, MD1-05-03K - MD1L5 - Seminar Room
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K Discovery Panel, the industry’s…
BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete DNA-informed multiomic view of the cellular ecosystem, today announced that it will introduce innovative new products and present…
Feb 5th 2024, Monday, 2-3.30pm NTU EMB building, Level 6 (#EMB-06-MR2)
Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched a killer new lentivirus application on Leprechaun today. Leprechaun could…